InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
DNA synthesis inhibitor | Poly(ethylene glycol)–Poly(beta-amino ester)-Based Nanoparticles for Suicide ... | 2020 | CS Biomater. Sci. Eng. | Kim J. et al. | DOI: 10.1021/acsbiomaterials.0c00116 |
Human TLR2 and TLR1 Reporter HEK293 Cells (NF-κB) | Identification and validation of a novel dual small-molecule TLR2/8 antagonist. | 2020 | Biochem Pharmacol. | Grabowski M. et al. | DOI: 10.1016/j.bcp.2020.113957 |
Human TLR8 Reporter HEK293 Cells (NF-κB) | Identification and validation of a novel dual small-molecule TLR2/8 antagonist. | 2020 | Biochem Pharmacol. | Grabowski M. et al. | DOI: 10.1016/j.bcp.2020.113957 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | Identification and validation of a novel dual small-molecule TLR2/8 antagonist. | 2020 | Biochem Pharmacol. | Grabowski M. et al. | DOI: 10.1016/j.bcp.2020.113957 |
Human TLR7 Reporter HEK293 Cells (NF-κB) | Identification and validation of a novel dual small-molecule TLR2/8 antagonist. | 2020 | Biochem Pharmacol. | Grabowski M. et al. | DOI: 10.1016/j.bcp.2020.113957 |
Fc-hDectin-1a | Fluconazole and Lipopeptide Surfactin Interplay During Candida albicans Plasm... | 2020 | Pharmaceutics. | Suchodolski J. et al. | DOI: 10.3390/pharmaceutics12040314 |
Poly(A:U) | Analysis of RNA Interference (RNAi) Biopesticides: Double-Stranded RNA (dsRNA... | 2020 | Environ Sci Technol. | Zhang K. et al. | DOI: 10.1021/acs.est.9b07781 |
3p-hpRNA - RIG-I agonist | Baby's First Macrophage: Temporal Regulation of Hofbauer Cell Phenotype Influ... | 2020 | J Immunol. | Swieboda D. et al. | DOI: 10.4049/jimmunol.1901185 |
Rapamycin | Insulin activates hepatic Wnt/β-catenin signaling through stearoyl-CoA desatu... | 2020 | Sci Rep. | Cabrae R. et al. | DOI: 10.1038/s41598-020-61869-4 |
THP1-Dual™ Cells | Noncanonical STAT1 phosphorylation expands its transcriptional activity into ... | 2020 | Sci Signal. | Metwally H. et al. | DOI: 10.1126/scisignal.aay0574 |
THP1-Dual™ KO-IFNAR2 Cells | Noncanonical STAT1 phosphorylation expands its transcriptional activity into ... | 2020 | Sci Signal. | Metwally H. et al. | DOI: 10.1126/scisignal.aay0574 |
PMA - Phorbol myristate acetate | Noncanonical STAT1 phosphorylation expands its transcriptional activity into ... | 2020 | Sci Signal. | Metwally H. et al. | DOI: 10.1126/scisignal.aay0574 |
THP1-Dual™ KO-MyD88 Cells | Noncanonical STAT1 phosphorylation expands its transcriptional activity into ... | 2020 | Sci Signal. | Metwally H. et al. | DOI: 10.1126/scisignal.aay0574 |
HKLM | Runx1 negatively regulates inflammatory cytokine production by neutrophils in... | 2020 | Blood Adv. | Bellissimo D.C. et al. | DOI: 10.1182/bloodadvances.2019000785 |
U0126 | Berberine Hampers Influenza A Replication through Inhibition of MAPK/ERK Path... | 2020 | Viruses | Botwina P. et al. | DOI: 10.3390/v12030344 |
Pam3CSK4 | Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and... | 2020 | Cell | Zheng M. et al. | DOI: 10.1016/j.cell.2020.03.040. |
Puromycin | Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and... | 2020 | Cell | Zheng M. et al. | DOI: 10.1016/j.cell.2020.03.040. |
Poly(I:C) LMW | Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and... | 2020 | Cell | Zheng M. et al. | DOI: 10.1016/j.cell.2020.03.040. |
Poly(dA:dT) | Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and... | 2020 | Cell | Zheng M. et al. | DOI: 10.1016/j.cell.2020.03.040. |
LPS-EB (LPS from E. coli O111:B4) | Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and... | 2020 | Cell | Zheng M. et al. | DOI: 10.1016/j.cell.2020.03.040. |